Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

10.1001/archinte.1910.00050330050003

Konotey‐Ahulu FI, 1974, The sickle cell diseases. Clinical manifestations including the “sickle crisis”, Arch Intern Med, 133, 611, 10.1001/archinte.1974.00320160105009

Yater WM, 1936, Sickle‐cell anemia: A new cause of cor pulmonale: Report of two cases with numerous disseminated occlusions of the small pulmonary arteries, Am J Med Sci, 191, 474, 10.1097/00000441-193604000-00004

Hebbel RP, 1985, The adhesive sickle erythrocyte: Cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes, Clin Haematol, 14, 141, 10.1016/S0308-2261(21)00466-5

10.1073/pnas.86.9.3356

10.1002/ajh.2830360211

10.1002/(SICI)1096-8652(199805)58:1<61::AID-AJH11>3.0.CO;2-8

10.1111/j.1365-2141.2004.05025.x

10.1056/NEJMoa035477

10.1001/jama.294.1.81

10.1038/nm1202-799

10.1182/blood-2005-06-2373

10.1016/j.blre.2006.07.001

10.1017/CBO9780511546198

10.1080/10739680490278402

10.1056/NEJM199711273372203

10.1016/S0002-9440(10)64037-0

10.1080/10739680490437559

10.1067/mlc.2001.115450

10.1182/blood-2003-10-3719

Francis RB, 1994, Sickle Cell Disease, 229

10.1182/blood.V97.6.1584

10.1152/ajpregu.2000.279.6.R1949

10.1080/10739680490278592

10.1182/blood.V96.1.314

10.1172/JCI9225

10.1182/blood-2002-09-2791

10.1038/ng1533

10.1182/blood-2007-06-097188

10.1182/blood-2007-02-074849

10.1182/blood.V70.5.1245.1245

10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6

10.1182/blood.V97.7.1937

10.1038/288373a0

10.1161/01.RES.61.6.866

10.1038/333664a0

10.1161/01.CIR.87.5.1468

10.1172/JCI118074

10.1038/nbt0798-672

10.1056/NEJMcibr023045

10.1097/00062752-200303000-00001

10.1161/CIRCULATIONAHA.107.729137

10.1056/NEJMra0804411

10.1002/ajh.21184

10.3324/haematol.12928

10.1111/j.1365-2141.2009.07658.x

10.1182/blood-2008-03-142604

10.1001/jama.293.13.1653

10.1161/CIRCULATIONAHA.106.658641

10.1182/blood-2006-12-061697

10.3324/haematol.11763

10.3324/haematol.12632

10.1182/blood-2006-08-039438

10.1038/nm1499

10.1182/blood-2007-06-095646

10.1084/jem.20070819

10.1111/j.1365-2141.2006.06110.x

10.1002/ajh.21058

10.1182/blood-2002-03-0948

10.1016/j.amjmed.2004.03.034

10.1001/jama.296.3.310

10.1056/NEJMp038250

10.1111/j.1365-2141.2005.05432.x

10.1161/hc4801.100076

10.1007/s00246-007-9018-x

10.1080/08880010601185892

10.3324/haematol.13812

10.1097/MPH.0b013e31818e5343

10.1111/j.1365-2141.2008.07501.x

Lee MT, 2007, Pulmonary hypertension in sickle cell disease, Clin Adv Hematol Oncol, 5, 645

10.1002/pbc.20791

10.1111/j.1365-2141.2007.06822.x

10.1002/ppul.20996

10.1056/NEJM199807023390102

Olnes M, Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea, Am J Hematol

10.1001/jama.2008.598

10.1182/asheducation-2008.1.186

10.1002/ajh.21187

10.1016/j.echo.2007.06.001

10.2143/AC.60.5.2004966

10.1016/0735-1097(91)90634-L

10.1016/j.jacc.2006.09.038

10.1164/rccm.200610-1498OC

10.1111/j.1365-2141.2006.06417.x

10.1164/rccm.200710-1606OC

Ohene‐Frempong K, 1998, Cerebrovascular accidents in sickle cell disease: Rates and risk factors, Blood, 91, 288

10.1002/ana.410200606

10.1053/hupa.2002.128059

10.1002/ajh.20642

10.1182/blood-2008-03-143891

10.1097/00043426-200308000-00007

10.1159/000102588

10.1111/j.1365-2141.2006.06074.x

10.1182/blood-2005-04-1594

10.1016/j.urology.2005.11.045

10.1111/j.1743-6109.2006.00333.x

10.1073/pnas.0407183102

10.1016/S0002-9343(02)01165-8

10.1111/j.1365-2141.2007.06822.x

10.1016/j.tracli.2008.03.013

10.3324/haematol.12119

10.1152/ajpheart.01068.2007

10.1182/blood-2007-04-084061

Kasschau MR, 1996, Adhesion of sickle neutrophils and erythrocytes to fibronectin, Blood, 87, 771, 10.1182/blood.V87.2.771.bloodjournal872771

10.1111/j.1365-2141.1991.tb04461.x

10.1111/j.1365-2141.2000.02353.x

10.1111/j.1365-2141.2008.07056.x

10.1182/blood.V96.7.2451

10.1161/01.ATV.0000220374.00602.a2

10.1016/S0022-2143(97)90005-6

10.1111/j.1365-2141.2004.05295.x

10.1111/j.1365-2141.2007.06560.x

10.1086/506356

Nagel RL, 1991, The distinct pathobiology of sickle cell‐hemoglobin C disease. Therapeutic implications, Hematol Oncol Clin North Am, 5, 433

Serjeant GR, 1975, Fetal haemoglobin in homozygous sickle cell disease, Clin Haematol, 4, 109, 10.1016/S0308-2261(21)00626-3

10.1002/ajh.2830240105

10.1056/NEJM198307213090320

10.1056/NEJM198202043060504

10.1182/blood-2007-08-110098

10.1089/ars.2007.1576

10.1038/35051594

10.1189/jlb.0708445

10.1172/JCI26857

10.1023/A:1015957026924

10.1111/j.1365-2141.2006.06277.x

Hebbel RP, 1985, Auto‐oxidation and a membrane‐associated ‘Fenton reagent’: A possible explanation for development of membrane lesions in sickle erythrocytes, Clin Haematol, 14, 129, 10.1016/S0308-2261(21)00465-3

10.1182/blood.V78.10.2753.2753

10.1152/ajpheart.01150.2003

10.1073/pnas.221292098

Aslan M, 2004, Oxidant‐mediated impairment of nitric oxide signaling in sickle cell disease‐‐mechanisms and consequences, Cell Mol Biol (Noisy‐le‐grand), 50, 95

10.1074/jbc.M802402200

10.1096/fj.04-3218fje

10.1073/pnas.93.13.6770

10.1042/bj2810627

10.1007/s00277-004-0856-9

10.1046/j.1365-2141.2003.04109.x

10.1002/(SICI)1096-8652(199907)61:3<216::AID-AJH11>3.0.CO;2-E

10.1016/0009-8981(70)90063-X

10.1164/rccm.200208-967OC

10.1097/00043426-200308000-00008

10.1161/01.ATV.0000243924.00970.cb

10.2174/1389200024605154

10.1016/j.tips.2008.10.003

10.1182/blood-2007-04-081703

El Rassi F, 2008, Beta‐thalassemia intermedia: An overview, Pediatr Ann, 37, 322